new boxed warning about serious liver toxicity in patients taking Tasmar (tolcapone)

You'll see a new boxed warning about serious liver toxicity in patients taking Tasmar (tolcapone).

Tasmar came out earlier this year. It's used to prolong the effect of levodopa in patients with advanced Parkinson's.

Now there are several reports of liver toxicity...including three deaths.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote